HIV-associated lung infections and complications in the era of combination antiretroviral therapy.
about
Factors associated with abnormal spirometry among HIV-infected individualsMechanisms Underlying HIV Associated Non-infectious Lung Disease.Thoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.High prevalence of malignancy in HIV-positive patients with mediastinal lymphadenopathy: a study in the era of antiretroviral therapy.Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening.HIV-associated obstructive lung diseases: insights and implications for the clinician.Safety of varenicline among smokers enrolled in the lung HIV study.Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort.Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.Comparing clinical outcomes in HIV-infected and uninfected older men hospitalized with community-acquired pneumoniaHIV infection is associated with reduced pulmonary diffusing capacity.Lung Malignancies in HIV Infection.Adherence to Tobacco Dependence Treatment Among HIV-Infected Smokers.The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohortGender Differences in Pulmonary Function, Respiratory Symptoms, and Macrophage Proteomics among HIV-Infected Smokers.The clinical implications of HIV infection and aging.Long-term effects of severe acute malnutrition on lung function in Malawian children: a cohort study.The respiratory microbiome of HIV-infected individuals.Bronchiectasis and other chronic lung diseases in adolescents living with HIV.Non-infectious pulmonary disorders in HIV.Mechanisms of HIV persistence in HIV reservoirs.The Differential Impact of Emphysema on Respiratory Symptoms and 6-Minute Walk Distance in HIV Infection.Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected MacaquesRisk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients.Human immunodeficiency virus associated pulmonary conditions leading to hospital admission and the pulmonary rehabilitation services received by patients at two central hospitals in Harare.
P2860
Q28388780-19A3570D-DABC-4DB6-B93F-A5046C360B76Q30234727-E67CA650-BD96-4D97-85DA-E452C8683BB6Q30364647-DE9DACBB-A3C5-441A-AFBF-0D2AE1829830Q33593553-C1FE4622-D86B-436F-8804-397AD0DA3E6AQ33600046-5F06BAD9-0C1D-4242-926D-C75E7EDF8982Q33950594-A075987C-9A1F-49C7-B894-92A1AC37C622Q36471990-4C438AB7-77A4-471F-802A-6EF992E3870DQ36629915-4B390569-1E09-4DBE-9788-9EF6D8996B04Q37102014-ABF0DA0B-5F58-43C6-8579-867195E1302AQ37240889-5C575111-9E00-4305-8A11-0040E6935A10Q37354530-2D63345C-A4AC-4989-9F14-7B7B2C07FF5FQ37478443-2BBC921D-FF5E-4A63-B04A-B1A4361643D5Q37600952-C983E34F-FD5C-4F90-BAE9-00BECC035D16Q37636248-6DE979B4-F77D-4956-99C1-AF29C95F9AD4Q37651113-A9699820-62BA-4000-BC05-E7E9E8D6C43FQ38816195-0ED28502-0214-4A91-9990-484BAE037666Q38851694-A2D9B5E9-1D36-48FD-941F-5421104994BFQ38878361-CA787255-CF36-4904-A6C6-FB3D3CBA8353Q38883323-17CFF6AB-F1AA-4BF5-BAF0-6D0AFD46EB7EQ39106214-65672CB7-D56D-47EF-BB25-793A3708FBFDQ39106572-8009AF7D-B88A-40A8-933E-4C5CCD7AA9F6Q40513699-01E10D62-CD6D-44F1-8D62-6D8B85B26DB3Q40734962-2036FCB0-EE1E-44D7-8035-2504B4ED495CQ40833745-FEF1AAE7-F8E6-42E1-8C2B-1AD4F0ACDACFQ55434353-1927134C-475C-4014-8E84-9D61C6975E12
P2860
HIV-associated lung infections and complications in the era of combination antiretroviral therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HIV-associated lung infections ...... nation antiretroviral therapy.
@ast
HIV-associated lung infections ...... nation antiretroviral therapy.
@en
HIV-associated lung infections ...... nation antiretroviral therapy.
@nl
type
label
HIV-associated lung infections ...... nation antiretroviral therapy.
@ast
HIV-associated lung infections ...... nation antiretroviral therapy.
@en
HIV-associated lung infections ...... nation antiretroviral therapy.
@nl
prefLabel
HIV-associated lung infections ...... nation antiretroviral therapy.
@ast
HIV-associated lung infections ...... nation antiretroviral therapy.
@en
HIV-associated lung infections ...... nation antiretroviral therapy.
@nl
P2093
P2860
P3181
P1476
HIV-associated lung infections ...... nation antiretroviral therapy.
@en
P2093
Burkhardt K
Chaisson RE
Crothers K
Thompson BW
P2860
P304
P3181
P356
10.1513/PATS.201009-059WR
P577
2011-06-01T00:00:00Z